{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:22:18Z","timestamp":1792628538702,"version":"4.5.0"},"reference-count":90,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by inflammation of the synovium. The inflammation accelerates the development and progression of atherosclerosis, a key phenomenon in the onset of cardiovascular diseases. The aim of this review was to synthetize the traditional and RA-specific cardiovascular risk (CVR) factors and the CVR assessment guidelines in RA patients. Methods: We performed a PubMed search using specific keywords. We synthetized the main findings. Results: Although the risk factors are the traditional ones, with certain particularities, the mechanisms that lead to cardiovascular disease are distinguished. In RA, the \u201clipid paradox\u201d occurs: low levels of total cholesterol and low-density lipoprotein (LDL)-cholesterol, and high levels of high-density lipoprotein (HDL)-cholesterol. Despite this phenomenon, patients have an elevated risk of cardiovascular events. This is due to inflammation, which increases cholesterol catabolism and interferes with the anti-oxidant properties of HDL-cholesterol. There is a significant association between serum C-reactive protein (CRP) value and cardiovascular risk: each 20 mg\/L increase in CRP causes a 1% increase in cardiovascular risk. The evaluation of the CVR through standard matrices undervalues the risk in patients with RA. Various approaches have been suggested to improve the accuracy of cardiovascular risk appraisal: from multiplying standard scores, including specific biomarkers, to modifying the impact of certain parameters in risk calculation. Conclusions: RA inflammatory and autoimmune mechanisms increase the cardiovascular morbidity and mortality in this group of patients. Therefore, this category of patients requires a proper cardiovascular (CV) evaluation. Carotid ultrasound ensures a better classification of RA patients, especially women, in the cardiovascular risk categories.<\/jats:p>","DOI":"10.3390\/jcm14186461","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T11:51:43Z","timestamp":1757937103000},"page":"6461","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5960-775X","authenticated-orcid":false,"given":"Ruxandra","family":"Oiegar","sequence":"first","affiliation":[{"name":"4th Department of Internal Medicine, Department of Cardiology Rehabilitation, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Doctoral School, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1744-7952","authenticated-orcid":false,"given":"Dana","family":"Pop","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Department of Cardiology Rehabilitation, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Department of Cardiology Rehabilitation, Clinical Rehabilitation Hospital, 400437 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2024.07.016","article-title":"Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis","volume":"128","author":"Drosos","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bedekovi\u0107, D., Bo\u0161njak, I., Bili\u0107-\u0106ur\u010di\u0107, I., Kirner, D., \u0160ari\u0107, S., and Novak, S. (2024). Risk for cardiovascular disease development in rheumatoid arthritis. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-024-03963-3"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s10067-024-06996-3","article-title":"Cardiovascular disease risk assessment in patients with rheumatoid arthritis: A scoping review","volume":"43","author":"Murphy","year":"2024","journal-title":"Clin. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41440-020-0483-4","article-title":"Cardiovascular disease and subclinical atherosclerosis in rheumatoid arthritis","volume":"43","author":"Hannawi","year":"2020","journal-title":"Hypertens. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13075-020-02384-9","article-title":"Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: A prospective cohort study","volume":"23","author":"Rohrich","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"ref_6","first-page":"j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study","volume":"357","author":"Coupland","year":"2017","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11886-025-02198-8","article-title":"Cardiovascular Risk Factor and Atherosclerosis in Rheumatoid Arthritis (RA)","volume":"27","author":"Kattamuri","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar3842","article-title":"High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: A cross-sectional study","volume":"14","author":"Arts","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.3390\/ijms151222279","article-title":"Smoking and rheumatoid arthritis","volume":"15","author":"Chang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10238-022-00816-1","article-title":"Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitus","volume":"23","author":"Li","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ruscitti, P., Ursini, F., Cipriani, P., Liakouli, V., Carubbi, F., Berardicurti, O., Sarro, G.D., and Giacomelli, R. (2017). Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the shortterm: A 1-year, single-centre, longitudinal study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181203"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Otsuka, Y., Kiyohara, C., Kashiwado, Y., Sawabe, T., Nagano, S., Kimoto, Y., Ayano, M., Mitoma, H., Akahoshi, M., and Arinobu, Y. (2018). Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196368"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/acr.20657","article-title":"Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti-tumor necrosis factor \u03b1 therapy","volume":"64","author":"Antohe","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lu, M.C., Yan, S.T., Yin, W.Y., Koo, M., and Lai, N.S. (2014). Risk of rheumatoid arthritis in patients with type 2 diabetes: A nationwide population-based case-control study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101528"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40259-022-00561-7","article-title":"Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association","volume":"36","author":"Cipriani","year":"2022","journal-title":"BioDrugs"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/03009742.2022.2070988","article-title":"Rheumatoid arthritis and the risk of major cardiometabolic diseases: A Mendelian randomization study","volume":"52","author":"Zhang","year":"2023","journal-title":"Scand. J. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.2147\/JMDH.S529217","article-title":"Causal Relationships Between Abdominal Obesity, Type 2 Diabetes, Fasting Insulin, and Cervical Disc Disorders, Osteoporosis, and Rheumatoid Arthritis: A Mendelian Randomization Study","volume":"18","author":"Tang","year":"2025","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e28763","DOI":"10.1097\/MD.0000000000028763","article-title":"Uncontrolled blood pressure among hypertensive adults with rheumatoid arthritis in Saudi Arabia: A cross-sectional study","volume":"101","author":"Almalki","year":"2022","journal-title":"Medicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00281-017-0632-2","article-title":"Cardiovascular risk in patients with rheumatoid arthritis","volume":"39","author":"Lauper","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Erlandsson, M.C., Lyngfelt, L., \u00c5berg, N.D., Was\u00e9n, C., Espino, R.A., Silfversw\u00e4rd, S.T., Nadali, M., Jood, K., Andersson, K.M.E., and Pullerits, R. (2019). Low serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritis. BMC Med., 17.","DOI":"10.1186\/s12916-019-1374-x"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3899\/jrheum.200056","article-title":"Abdominal Obesity in Comparison with General Obesity and Risk of Developing Rheumatoid Arthritis in Women","volume":"48","author":"Marchand","year":"2021","journal-title":"J. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhu, Y., Tang, X., Guo, Z., Li, J., Lv, S., Liu, M., Yu, Y., and Lei, C. (2025). Association of visceral fat metabolism score with risk of rheumatoid arthritis in US adults. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1544624"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1080\/19420862.2016.1216741","article-title":"The underlying inflammatory chronic disease influences infliximab pharmacokinetics","volume":"8","author":"Passot","year":"2016","journal-title":"MAbs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.2007.078832","article-title":"A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis","volume":"67","author":"Allaart","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Barrera, L., Perez-Sanchez, C., Ortega-Castro, R., Corrales, S., Luque-Tevar, M., Cerd\u00f3, T., Sanchez-Pareja, I., Font, P., L\u00f3pez-Mej\u00edas, R., and Calvo, J. (2024). Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs. Biomed. Pharmacother., 173.","DOI":"10.1016\/j.biopha.2024.116357"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejr.2011.03.005","article-title":"Non traditional risk factors for carotid atherosclerosis in rheumatoid arthritis","volume":"33","author":"Kassem","year":"2011","journal-title":"Egypt. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: A ten year follow up study of a primary care-based inception cohort","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2022.07.001","article-title":"\u201cCardiovascular, Obesity and Rheumatic Disease Study (CORDIS) Group\u201d of the Italian Society of Rheumatology (SIR). C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis","volume":"104","author":"Erre","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/art.39195","article-title":"Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: A Consortium of Rheumatology Researchers of North America Registry study","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e70028","DOI":"10.1111\/jcmm.70028","article-title":"Interleukin-6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients","volume":"28","author":"Roghani","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gerasimova, E.V., Popkova, T.V., Kirillova, I.G., Gerasimova, D.A., Nasonov, E.L., and Lila, A.M. (2024). Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212425"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/annrheumdis-2014-206411","article-title":"The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease","volume":"75","author":"Myasoedova","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/ard.2007.084459","article-title":"Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate","volume":"68","author":"Wells","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_35","first-page":"100721","article-title":"Levels of sCD163 in women rheumatoid arthritis: Relationship with cardiovascular risk markers","volume":"37","year":"2025","journal-title":"Clin. Investig. Arterioscler."},{"key":"ref_36","first-page":"689","article-title":"Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis","volume":"29","author":"Greisen","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Coradduzza, D., Cruciani, S., Di Lorenzo, B., De Miglio, M.R., Zinellu, A., Maioli, M., Medici, S., Erre, G.L., and Carru, C. (2025). Plasma Humanin and Non-Coding RNAs as Biomarkers of Endothelial Dysfunction in Rheumatoid Arthritis: A Pilot Study. Non-Coding RNA, 11.","DOI":"10.3390\/ncrna11010005"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Erre, G.L., Chessa, I., Bassu, S., Cavagna, L., Carru, C., Pintus, G., Giordo, R., Mangoni, A.A., Sanna, G.D., and Zinellu, A. (2024). Association between ischemia-modified albumin (IMA) and peripheral endothelial dysfunction in rheumatoid arthritis patients. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-54641-5"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/1756-185X.12946","article-title":"Ischemia modified albumin concentrations in patients with rheumatoid arthritis","volume":"20","author":"Varikasuvu","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7754\/Clin.Lab.2013.130143","article-title":"Assessment of ischemia-modified albumin levels in patients with rheumatoid arthritis","volume":"60","author":"Leitemperguer","year":"2014","journal-title":"Clin. Lab."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Pan, S.Y., Tian, H.M., Zhu, Y., Gu, W.J., Zou, H., Wu, X.Q., Cheng, R.J., and Yang, Z. (2022). Cardiac damage in autoimmune diseases: Target organ involvement that cannot be ignored. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1056400"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCRESAHA.121.319877","article-title":"Cardiovascular Implications of Immune Disorders in Women","volume":"130","author":"Moran","year":"2022","journal-title":"Circ. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3000605251315359","DOI":"10.1177\/03000605251315359","article-title":"Aspirin does not confer protection against major ischemic vascular events in patients diagnosed with rheumatoid arthritis","volume":"53","author":"Gao","year":"2025","journal-title":"J. Int. Med. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/annrheumdis-2016-211066","article-title":"Acute coronary syndrome in new-onset rheumatoid arthritis: A population-based nationwide cohort study of time trends in risks and excess risks","volume":"76","author":"Holmqvist","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3899\/jrheum.120941","article-title":"Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis","volume":"40","author":"McCoy","year":"2013","journal-title":"J Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Rus, M., Ardelean, A.I., Judea Pusta, C., Crisan, S., Marian, P., Pobirci, L.O., Huplea, V., Osiceanu, A.S., Osiceanu, G.A., and Andronie-Cioara, F.L. (2023). Prevalence of Cardiovascular Comorbidities in Patients with Rheumatoid Arthritis. Medicina, 60.","DOI":"10.20944\/preprints202311.1521.v1"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/rheumatology\/keae458","article-title":"Rheumatoid arthritis and the risk of ischaemic stroke after diagnosis of atrial fibrillation: A Norwegian nationwide register study","volume":"63","author":"Kerola","year":"2024","journal-title":"Rheumatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5455\/medarh.2025.79.127-134","article-title":"Rheumatoid Arthritis and Atrial Fibrillation: A Complex Cardiovascular Intersection\u2014Insights from a Retrospective Cohort Study","volume":"79","author":"Alqudah","year":"2025","journal-title":"Med. Arch."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/art.23935","article-title":"Cardiovascular, Rheumatologic, and Pharmacologic Predictors of Stroke in Patients with Rheumatoid Arthritis: A Nested, Case\u2013Control Study","volume":"59","author":"Nadareishvili","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s00415-018-8885-9","article-title":"Rheumatoid arthritis significantly increased recurrence risk after ischemic stroke\/transient ischemic attack","volume":"265","author":"Chen","year":"2018","journal-title":"J. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.amjmed.2003.09.039","article-title":"Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy","volume":"116","author":"Wolfe","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure","volume":"69","author":"Mantel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e12915","DOI":"10.1111\/eci.12915","article-title":"Development of heart failure in patients with rheumatoid arthritis: A Danish population-based study","volume":"48","author":"Ellingsen","year":"2018","journal-title":"Eur. J. Clin. Inv."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/art.23798","article-title":"The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population","volume":"58","author":"Davis","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/echo.13652","article-title":"Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis","volume":"34","author":"Bois","year":"2017","journal-title":"Echocardiography"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.amjcard.2007.03.048","article-title":"Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates","volume":"100","author":"Roldan","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e042025","DOI":"10.1161\/JAHA.125.042025","article-title":"Association Between Rheumatoid Arthritis and the Risk of Incident Degenerative Valvular Heart Disease: Evidence From a Prospective Cohort Study","volume":"14","author":"Wang","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e038815","DOI":"10.1161\/JAHA.124.038815","article-title":"Association Between Inflammatory Arthritis, Genetic Risk, and the Long-Term Risk of Degenerative Aortic Stenosis: A Prospective Cohort Study","volume":"14","author":"Peng","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.7150\/thno.71813","article-title":"The mechanistic pathways of oxidative stress in aortic stenosis and clinical implications","volume":"12","author":"Phua","year":"2022","journal-title":"Theranostics"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jamainternmed.2023.3087","article-title":"Aortic Stenosis Risk in Rheumatoid Arthritis","volume":"183","author":"Johnson","year":"2023","journal-title":"JAMA Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kim, A.R., Ji, E., Lee, S., Hong, S., Kim, D.H., Song, J.M., Kang, D.H., and Song, J.K. (2023). Association of citrullination with the progression of aortic stenosis. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-36153-w"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1160\/th15-07-0600","article-title":"Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis. A nationwide population-based cohort study","volume":"115","author":"Chuang","year":"2016","journal-title":"Thromb. Haemost."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00296-022-05245-7","article-title":"Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity","volume":"43","author":"Zoubi","year":"2023","journal-title":"Rheumatol. Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1161\/CIRCULATIONAHA.109.918417","article-title":"Inflammation in Peripheral Artery Disease","volume":"122","author":"Brevetti","year":"2010","journal-title":"Circulation"},{"key":"ref_66","first-page":"e9782","article-title":"Evaluation of the Risk of Getting Peripheral Artery Disease in Rheumatoid Arthritis and the Selection of Appropriate Diagnostic Methods","volume":"12","author":"Sedrakyan","year":"2020","journal-title":"Cureu"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-017-0667-3","article-title":"Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace","volume":"19","author":"Kishore","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/rheumatology\/ket475","article-title":"Vasculitis associated with rheumatoid arthritis: A case-control study","volume":"53","author":"Makol","year":"2014","journal-title":"Rheumatology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/ard.2009.110411","article-title":"Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis?","volume":"69","author":"Laskari","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.22057","article-title":"Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis","volume":"54","author":"Turesson","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"R1386","DOI":"10.1186\/ar1837","article-title":"The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis","volume":"7","author":"Turesson","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e030387","DOI":"10.1161\/JAHA.123.030387","article-title":"Interplay Between Systemic Inflammation, Myocardial Injury, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis: Results from the LiiRA Study","volume":"13","author":"Weber","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e007495","DOI":"10.1161\/CIRCIMAGING.117.007495","article-title":"Myocardial Microvascular Dysfunction in Rheumatoid ArthritisQuantitation by 13N-Ammonia Positron Emission Tomography\/Computed Tomography","volume":"12","author":"Amigues","year":"2019","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/acr.24108","article-title":"Coronary Microvascular Dysfunction in Rheumatoid Arthritis Compared to Diabetes Mellitus and Association with All-Cause Mortality","volume":"73","author":"Liao","year":"2021","journal-title":"Arthritis Car. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e000771","DOI":"10.1136\/rmdopen-2018-000771","article-title":"Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: An external validation","volume":"4","author":"Ljung","year":"2018","journal-title":"RMD Open"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10067-010-1425-3","article-title":"Leflunomide in the treatment of patients with early rheumatoid arthritis--results of a prospective non-interventional study","volume":"29","author":"Kellner","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","article-title":"Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"110","author":"Crowson","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","article-title":"Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis","volume":"74","author":"Arts","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3899\/jrheum.190261","article-title":"Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review","volume":"47","author":"Colaco","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/annrheumdis-2014-206879","article-title":"Prediction of cardiovascular risk in rheumatoid arthritis: Performance of original and adapted SCORE algorithms","volume":"75","author":"Arts","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3899\/jrheum.171008","article-title":"Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC\/AHA Risk Calculator","volume":"46","author":"Wahlin","year":"2019","journal-title":"J. Rheumatol."},{"key":"ref_84","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"25","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/art.38944","article-title":"The ability of the 2013 American College of Cardiology\/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores","volume":"67","author":"Kawai","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijcard.2016.08.129","article-title":"Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases","volume":"223","author":"Semb","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.11078","article-title":"Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects","volume":"48","author":"Williams","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.medcli.2022.01.017","article-title":"Cardiovascular risk assessment with carotid ultrasound in rheumatoid arthritis","volume":"159","year":"2022","journal-title":"Med. Clin."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Skeoch, S., Cristinacce, P.L.H., Williams, H., Pemberton, P., Xu, D., Sun, J., James, J., Yuan, C., Hatsukami, T., and Hockings, P.D. (2017). Imaging atherosclerosis in rheumatoid arthritis: Evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-00989-w"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6461\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:45:08Z","timestamp":1760035508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":90,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14186461"],"URL":"https:\/\/doi.org\/10.3390\/jcm14186461","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,13]]}}}